BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38634223)

  • 1. Are asymptomatic carriers of OTC deficiency always asymptomatic? A multicentric retrospective study of risk using the UCDC longitudinal study database.
    Sen K; Izem R; Long Y; Jiang J; Konczal LL; McCarter RJ; ; Gropman AL; Bedoyan JK
    Mol Genet Genomic Med; 2024 Apr; 12(4):e2443. PubMed ID: 38634223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An integrated approach to the diagnosis and prospective management of partial ornithine transcarbamylase deficiency.
    Scaglia F; Zheng Q; O'Brien WE; Henry J; Rosenberger J; Reeds P; Lee B
    Pediatrics; 2002 Jan; 109(1):150-2. PubMed ID: 11773558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperammonemia in ornithine transcarbamylase-deficient recipients following living donor liver transplantation from heterozygous carrier donors.
    Rahayatri TH; Uchida H; Sasaki K; Shigeta T; Hirata Y; Kanazawa H; Mali V; Fukuda A; Sakamoto S; Kasahara M
    Pediatr Transplant; 2017 Feb; 21(1):. PubMed ID: 27891735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Father-to-daughter transmission in late-onset OTC deficiency: an underestimated mechanism of inheritance of an X-linked disease.
    Siri B; Olivieri G; Lepri FR; Poms M; Goffredo BM; Commone A; Novelli A; Häberle J; Dionisi-Vici C
    Orphanet J Rare Dis; 2024 Jan; 19(1):3. PubMed ID: 38167094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A simple screening method for heterozygous female patients with ornithine transcarbamylase deficiency.
    Iijima H; Kubota M
    Mol Genet Metab; 2022 Nov; 137(3):301-307. PubMed ID: 36252454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal treatment of ornithine transcarbamylase deficiency.
    Wilnai Y; Blumenfeld YJ; Cusmano K; Hintz SR; Alcorn D; Benitz WE; Berquist WE; Bernstein JA; Castillo RO; Concepcion W; Cowan TM; Cox KL; Lyell DJ; Esquivel CO; Homeyer M; Hudgins L; Hurwitz M; Palma JP; Schelley S; Akula VP; Summar ML; Enns GM
    Mol Genet Metab; 2018 Mar; 123(3):297-300. PubMed ID: 29396029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impairment of cognitive function in ornithine transcarbamylase deficiency is global rather than domain-specific and is associated with disease onset, sex, maximum ammonium, and number of hyperammonemic events.
    Buerger C; Garbade SF; Dietrich Alber F; Waisbren SE; McCarter R; Kölker S; Burgard P;
    J Inherit Metab Dis; 2019 Mar; 42(2):243-253. PubMed ID: 30671983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperammonemia in a Woman with Late-onset Ornithine Transcarbamylase Deficiency.
    Koya Y; Shibata M; Senju M; Honma Y; Hiura M; Ishii M; Matsumoto S; Harada M
    Intern Med; 2019 Apr; 58(7):937-942. PubMed ID: 30449781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigating neurological deficits in carriers and affected patients with ornithine transcarbamylase deficiency.
    Sprouse C; King J; Helman G; Pacheco-Colón I; Shattuck K; Breeden A; Seltzer R; VanMeter JW; Gropman AL
    Mol Genet Metab; 2014; 113(1-2):136-41. PubMed ID: 24881970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperammonemic encephalopathy in a child with ornithine transcarbamylase deficiency due to a novel combined heterozygous mutations.
    Gao J; Gao F; Hong F; Yu H; Jiang P
    Am J Emerg Med; 2015 Mar; 33(3):474.e1-3. PubMed ID: 25227973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel mutation of the ornithine transcarbamylase gene leading to fatal hyperammonemia in a liver transplant recipient.
    Mukhtar A; Dabbous H; El Sayed R; Aboulfetouh F; Bahaa M; Abdelaal A; Fathy M; El-Meteini M
    Am J Transplant; 2013 Apr; 13(4):1084-1087. PubMed ID: 23551631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Consensus on diagnosis and treatment of ornithine trans-carbamylase deficiency].
    Division of Genetics and Metabolism, Child Diseases and Health Care Branch, Chinese Association for Maternal and Child Health
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2020 Oct; 49(5):539-547. PubMed ID: 33210478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corticosteroid suppresses urea-cycle-related gene expressions in ornithine transcarbamylase deficiency.
    Imoto K; Tanaka M; Goya T; Aoyagi T; Takahashi M; Kurokawa M; Tashiro S; Kato M; Kohjima M; Ogawa Y
    BMC Gastroenterol; 2022 Mar; 22(1):144. PubMed ID: 35346058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of the liver enzyme ornithine carbamoyltransferase (OTC) in blood: LC-MS/MS assay for non-invasive diagnosis of ornithine carbamoyltransferase deficiency.
    Krijt J; Sokolová J; Ješina P; Dvořáková L; Řeboun M; Brennerová K; Mistrík M; Zeman J; Honzík T; Kožich V
    Clin Chem Lab Med; 2017 Jul; 55(8):1168-1177. PubMed ID: 28107167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of neurocognitive function of prefrontal cortex in ornithine transcarbamylase deficiency.
    Anderson A; Gropman A; Le Mons C; Stratakis C; Gandjbakhche A
    Mol Genet Metab; 2020 Mar; 129(3):207-212. PubMed ID: 31952925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving long term outcomes in urea cycle disorders-report from the Urea Cycle Disorders Consortium.
    Waisbren SE; Gropman AL; ; Batshaw ML
    J Inherit Metab Dis; 2016 Jul; 39(4):573-84. PubMed ID: 27215558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late-Onset Ornithine Transcarbamylase Deficiency and Variable Phenotypes in Vietnamese Females With
    Nguyen HH; Khanh Nguyen N; Dung Vu C; Thu Huong Nguyen T; Nguyen NL
    Front Pediatr; 2020; 8():321. PubMed ID: 32793520
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical and molecular characteristics of 69 Chinese patients with ornithine transcarbamylase deficiency.
    Lu D; Han F; Qiu W; Zhang H; Ye J; Liang L; Wang Y; Ji W; Zhan X; Gu X; Han L
    Orphanet J Rare Dis; 2020 Dec; 15(1):340. PubMed ID: 33272297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A promoter variant in the OTC gene associated with late and variable age of onset hyperammonemia.
    Han ST; Anderson KJ; Bjornsson HT; Longo N; Valle D
    J Inherit Metab Dis; 2022 Jul; 45(4):710-718. PubMed ID: 35605046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Silico Analysis of a De Novo OTC Variant as a Cause of Ornithine Transcarbamylase Deficiency.
    Ozdemir Y; Cag M; Gul S; Yüksel Z; Ergoren MC
    Appl Immunohistochem Mol Morphol; 2022 Feb; 30(2):153-156. PubMed ID: 34670952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.